CAITLIN CECIL: Open Payments
NPI 1992106322 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,342 in 243 payments from 22 companies in 2025. Trend: 2023 $2,151 · 2024 $3,403 · 2025 $4,342
Food & beverage: $4,342
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 57 | $1,146 |
| Janssen Biotech, Inc. | 28 | $604 |
| Phathom Pharmaceuticals, Inc. | 54 | $450 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $365 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $357 |
| GENZYME CORPORATION | 12 | $246 |
| Ardelyx, Inc. | 10 | $220 |
| Lilly USA, LLC | 8 | $160 |
| QOL Medical, LLC | 4 | $107 |
| Madrigal Pharmaceuticals | 4 | $100 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, XIFAXAN, DUPIXENT, SKYRIZI, ENTYVIO, IBSRELA.
Industry payments across KY — which companies pay providers there.
